$AIXN
AiXin Life International, Inc. Stock $aixn

$aixn Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000149315223029386 Filed on August 18, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q2
Revenue	$1.067M	$1.476M	$420.9K
YoY Change	58.58%	250.7%	-50.64%
Cost Of Revenue	$960.0K	$910.0K	$572.1K
YoY Change	54.91%	59.06%	2186.57%
Gross Profit	$110.0K	$560.0K	-$151.2K
YoY Change	107.23%	-470.35%	-118.27%
Gross Profit Margin	10.31%	37.94%	-35.93%
Selling, General & Admin	$710.5K	$582.0K	$474.7K
YoY Change	66.61%	22.6%	78.22%
% of Gross Profit	645.95%	103.93%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$114.3K	$88.51K	$27.58K
YoY Change	344.75%	220.92%	657.69%
% of Gross Profit	103.91%	15.81%
Operating Expenses	$1.802M	$1.581M	$1.160M
YoY Change	49.35%	36.26%	201.91%
Operating Profit	-$735.3K	-$104.8K	-$739.2K
YoY Change	37.71%	-85.83%	-257.79%
Interest Expense	$0.00	$0.00	$1.280K
YoY Change	-100.0%	-100.0%	0.79%
% of Operating Profit
Other Income/Expense, Net	$297.6K	$12.13K	$11.44K
YoY Change	-107.75%	6.0%	-403.74%
Pretax Income	-$437.6K	-$92.64K	-$727.8K
YoY Change	-89.99%	-87.27%	-256.6%
Income Tax	$515.00	$4.907K	$473.00
% Of Pretax Income
Net Earnings	-$438.2K	-$97.55K	-$728.3K
YoY Change	-89.98%	-86.61%	-395.22%
Net Earnings / Revenue	-41.07%	-6.61%	-173.03%
Basic Earnings Per Share	-$0.02	$0.00	-$0.02
Diluted Earnings Per Share	-$0.02	$0.00	-$14.57K
COMMON SHARES
Basic Shares Outstanding	25.00M shares	25.00M shares	50.00M shares
Diluted Shares Outstanding	25.00M shares	25.00M shares	25.00M shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$410.0K	$320.0K	$8.130M
YoY Change	-92.26%	-96.06%	150.25%
Cash & Equivalents	$412.7K	$316.9K	$8.130M
Short-Term Investments
Other Short-Term Assets	$590.0K	$260.0K	$163.6K
YoY Change	99.94%	58.92%	-96.71%
Inventory	$643.6K	$625.8K	$291.9K
Prepaid Expenses
Receivables	$250.6K	$345.5K	$60.55K
Other Receivables	$30.00K	$134.3K	$27.06K
Total Short-Term Assets	$2.065M	$1.743M	$8.816M
YoY Change	-69.75%	-80.23%	5.05%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.659M	$1.701M	$222.0K
YoY Change	-13.18%	666.5%	56.57%
Goodwill
YoY Change
Intangibles	$2.840K	$3.241K	$594.00
YoY Change	103.88%	445.62%
Long-Term Investments	$80.00K	$80.00K	$89.58K
YoY Change	-5.16%	-10.69%
Other Assets	$10.00K	$10.00K	$16.95K
YoY Change	-35.57%	-41.0%
Total Long-Term Assets	$2.215M	$2.484M	$1.774M
YoY Change	-30.47%	40.04%	1151.24%
TOTAL ASSETS
Total Short-Term Assets	$2.065M	$1.743M	$8.816M
Total Long-Term Assets	$2.215M	$2.484M	$1.774M
Total Assets	$4.280M	$4.227M	$10.59M
YoY Change	-57.25%	-60.08%	24.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$600.0K	$470.8K	$472.9K
YoY Change	18.11%	-0.44%	1096.2%
Accrued Expenses	$2.530M	$2.700M	$1.802M
YoY Change	-61.76%	49.83%	217.53%
Deferred Revenue
YoY Change
Short-Term Debt	$80.00K	$80.00K	$89.58K
YoY Change	-5.16%	-10.69%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.067M	$4.637M	$5.213M
YoY Change	-45.44%	-11.05%	503.1%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$160.0K	$210.0K	$614.8K
YoY Change	-58.13%	-65.84%	1220.14%
Total Long-Term Liabilities	$160.0K	$210.0K	$614.8K
YoY Change	-58.13%	-65.84%	1220.14%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.067M	$4.637M	$5.213M
Total Long-Term Liabilities	$160.0K	$210.0K	$614.8K
Total Liabilities	$5.225M	$4.843M	$5.828M
YoY Change	-45.96%	-16.9%	539.76%
SHAREHOLDERS EQUITY
Retained Earnings	-$16.20M	-$15.76M	-$10.36M
YoY Change	9.91%	52.08%
Common Stock	$250.00	$250.00	$500.00
YoY Change	-50.0%	-50.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$945.1K	-$615.9K	$4.762M
YoY Change
Total Liabilities & Shareholders Equity	$4.280M	$4.227M	$10.59M
YoY Change	-57.25%	-60.08%	24.09%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q2
OPERATING ACTIVITIES
Net Income	-$438.2K	-$97.55K	-$728.3K
YoY Change	-89.98%	-86.61%	-395.22%
Depreciation, Depletion And Amortization	$114.3K	$88.51K	$27.58K
YoY Change	344.75%	220.92%	657.69%
Cash From Operating Activities	$130.0K	$120.0K	-$268.0K
YoY Change	-120.28%	-144.78%	-189.94%
INVESTING ACTIVITIES
Capital Expenditures	$210.0K	$10.00K
YoY Change	-500.08%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00
YoY Change	-100.0%
Cash From Investing Activities	-$200.0K	-$10.00K
YoY Change	-150.77%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	170.0K	-260.0K	274.4K
YoY Change	-107.38%	-194.76%	-192.71%
NET CHANGE
Cash From Operating Activities	130.0K	120.0K	-268.0K
Cash From Investing Activities	-200.0K	-10.00K
Cash From Financing Activities	170.0K	-260.0K	274.4K
Net Change In Cash	100.0K	-150.0K	6.410K
YoY Change	-103.92%	-2440.09%	-100.14%
FREE CASH FLOW
Cash From Operating Activities	$130.0K	$120.0K	-$268.0K
Capital Expenditures	$210.0K	$10.00K
Free Cash Flow	-$80.00K	$110.0K
YoY Change	-86.41%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Central Index Key EntityCentralIndexKey	0000835662
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
CY2023Q2	us-gaap	Goodwill Goodwill		usd
CY2022Q4	us-gaap	Goodwill Goodwill		usd
CY2023Q2	AIXN	Accounts Payable Related Party Current AccountsPayableRelatedPartyCurrent		usd
	AIXN	Provision For Inventory Reserve ProvisionForInventoryReserve		usd
	AIXN	Increase Decrease In Accounts Payable Related Party IncreaseDecreaseInAccountsPayableRelatedParty		usd
	AIXN	Cash Disposed At Disposal Of Subsidiary CashDisposedAtDisposalOfSubsidiary		usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	AIXN	Provision For Inventory Reserve ProvisionForInventoryReserve		usd
CY2023Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	0-17284
	dei	Entity Registrant Name EntityRegistrantName	AIXIN LIFE INTERNATIONAL, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CO
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-1085935
	dei	Entity Address Address Line1 EntityAddressAddressLine1	Hongxing International Business Building 2, 14th FL
	dei	Entity Address Address Line2 EntityAddressAddressLine2	No. 69 Qingyun South Ave.
	dei	Entity Address Address Line3 EntityAddressAddressLine3	Jinjiang District
	dei	Entity Address City Or Town EntityAddressCityOrTown	Chengdu City
	dei	Entity Address Country EntityAddressCountry	CN
	dei	City Area Code CityAreaCode	86
	dei	Local Phone Number LocalPhoneNumber	313-6732526
	dei	Security12b Title Security12bTitle	Common Stock, $0.00001 Par Value
	dei	Trading Symbol TradingSymbol	AIXN
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	No
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	24999842	shares
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	316905	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	510128	usd
CY2023Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	97625	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	109772	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	345500	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	562581	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	66331	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	42631	usd
CY2023Q2	us-gaap	Supplies Supplies	156745	usd
CY2022Q4	us-gaap	Supplies Supplies	168523	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	625752	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	499252	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	1743178	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	1975989	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1701307	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1971793	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3241	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1269	usd
CY2023Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	13934	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	15556	usd
CY2023Q2	us-gaap	Security Deposit SecurityDeposit	82744	usd
CY2022Q4	us-gaap	Security Deposit SecurityDeposit	86992	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	682694	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	999285	usd
CY2023Q2	us-gaap	Assets Assets	4227098	usd
CY2022Q4	us-gaap	Assets Assets	5050884	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	470770	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	398469	usd
CY2022Q4	AIXN	Accounts Payable Related Party Current AccountsPayableRelatedPartyCurrent	165958	usd
CY2023Q2	us-gaap	Deferred Revenue DeferredRevenue	126484	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	139502	usd
CY2023Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	103636	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	104100	usd
CY2023Q2	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	2143431	usd
CY2022Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	2356490	usd
CY2023Q2	AIXN	Government Grant GovernmentGrant	903962	usd
CY2022Q4	AIXN	Government Grant GovernmentGrant	950371	usd
CY2023Q2	us-gaap	Short Term Non Bank Loans And Notes Payable ShortTermNonBankLoansAndNotesPayable	82744	usd
CY2022Q4	us-gaap	Short Term Non Bank Loans And Notes Payable ShortTermNonBankLoansAndNotesPayable	86992	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	601626	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	883583	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	4637096	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5322347	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	205903	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	194725	usd
CY2023Q2	us-gaap	Liabilities Liabilities	4842999	usd
CY2022Q4	us-gaap	Liabilities Liabilities	5517072	usd
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24999842	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24999842	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24999842	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24999842	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	250	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	250	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	14789653	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	14458583	usd
CY2023Q2	AIXN	Statutory Reserves StatutoryReserves	151988	usd
CY2022Q4	AIXN	Statutory Reserves StatutoryReserves	151988	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-15757028	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-15249858	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	199236	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	172849	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-615901	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-466188	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4227098	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5050884	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1476057	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	420887	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2230770	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	839565	usd
CY2023Q2	AIXN	Cost Of Goods And Service Sold CostOfGoodsAndServiceSold	451200	usd
CY2022Q2	AIXN	Cost Of Goods And Service Sold CostOfGoodsAndServiceSold	153998	usd
	AIXN	Cost Of Goods And Service Sold CostOfGoodsAndServiceSold	626688	usd
	AIXN	Cost Of Goods And Service Sold CostOfGoodsAndServiceSold	278522	usd
CY2023Q2	AIXN	Hotel Operating Costs HotelOperatingCosts	462780	usd
CY2022Q2	AIXN	Hotel Operating Costs HotelOperatingCosts	418100	usd
	AIXN	Hotel Operating Costs HotelOperatingCosts	940574	usd
	AIXN	Hotel Operating Costs HotelOperatingCosts	929719	usd
CY2023Q2	us-gaap	Selling Expense SellingExpense	226575	usd
CY2022Q2	us-gaap	Selling Expense SellingExpense	200032	usd
	us-gaap	Selling Expense SellingExpense	417848	usd
	us-gaap	Selling Expense SellingExpense	389618	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	355422	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	274675	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	768481	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	519471	usd
CY2023Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-8037	usd
CY2022Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	20435	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-51853	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	47857	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	92885	usd
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	92885	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	185770	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	185770	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	1580825	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	1160125	usd
	us-gaap	Operating Expenses OperatingExpenses	2887508	usd
	us-gaap	Operating Expenses OperatingExpenses	2350957	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-104768	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-739238	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-656738	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1511392	usd
CY2023Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	268	usd
CY2022Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1284	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	557	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	2612	usd
CY2023Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	14241	usd
CY2022Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	10221	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	39102	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	29655	usd
CY2023Q2	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	2380	usd
CY2022Q2	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	63	usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	4887	usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	260	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	12129	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	11442	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	34772	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	32007	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-92639	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-727796	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-621966	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1479385	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4907	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	473	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5364	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	965	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-97546	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-728269	usd
	us-gaap	Net Income Loss NetIncomeLoss	-627330	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1480350	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1845	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-44948	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	26387	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-13084	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-95701	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-773217	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-600943	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1493434	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.004
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.004
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.029
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.029
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.025
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.025
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.059
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.059
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24999842	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24999842	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24999842	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24999842	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24999842	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24999842	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24999842	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24999842	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-466188	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	92885	usd
CY2023Q1	AIXN	Disposal Of Subsidiary DisposalOfSubsidiary	120160	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-529784	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	24542	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-758385	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	92885	usd
CY2023Q2	AIXN	Stock Issued During Period Capital Contribution StockIssuedDuringPeriodCapitalContribution	145300	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-97546	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1845	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-615901	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	6069491	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	92885	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-752081	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	31864	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	5442159	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	5442159	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	92885	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-728269	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-44948	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	4761827	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	4761827	usd
	us-gaap	Net Income Loss NetIncomeLoss	-627330	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1480350	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	193427	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	57219	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-51853	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	47857	usd
	AIXN	Provision For Inventory Reserve ProvisionForInventoryReserve	12026	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	417369	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	449445	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	185770	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	185770	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	902	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	965	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-249851	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	65284	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	46276	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-92619	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	24890	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	12043	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	170052	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	72168	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	98150	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	89349	usd
	AIXN	Increase Decrease In Accounts Payable Related Party IncreaseDecreaseInAccountsPayableRelatedParty	-165172	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-6552	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-10099	usd
	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	4839	usd
	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	-7034	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	405079	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	418711	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-65670	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	346883	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-350760	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-771496	usd
	AIXN	Cash Disposed At Disposal Of Subsidiary CashDisposedAtDisposalOfSubsidiary	-3392	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10627	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	2647	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16666	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	39677	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	779015	usd
	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	144300	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	183977	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	779015	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-21921	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-417088	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-205370	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-409569	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	619900	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8600853	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	414530	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8191284	usd
CY2023Q1	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1 for 2 reverse stock split
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24999842	shares
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-104768	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-739238	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-656738	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1511392	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-350760	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-771496	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-15757028	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	510128	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	316905	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84D_eus-gaap--UseOfEstimates_ziospgEpsuBj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white"><b><span id="xdx_861_zAbpxPfgPzwi">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">In preparing consolidated financial statements in conformity with US GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the consolidated financial statements, as well as the reported amounts of revenues and expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">Significant estimates required by management, include the recoverability of long-lived assets, allowance for doubtful accounts, and the reserve for obsolete and slow-moving inventories. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_848_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zeqwUWwvMwuj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white"><b><span id="xdx_869_z3PdBN36II97">Reclassification</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">Certain prior period amounts have been reclassified to conform to the current period presentation and had no effect on previously reported consolidated net income (loss) or accumulated deficit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	200044	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	272550	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	601626	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	883583	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	205903	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	194725	usd
	AIXN	Schedule Of Accounts Receivable Allowance For Doubtful Accounts ScheduleOfAccountsReceivableAllowanceForDoubtfulAccounts	<p id="xdx_89C_ecustom--ScheduleOfAccountsReceivableAllowanceForDoubtfulAccounts_zbp9XoTzNUk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">The following table summarizes the activity related to the Company’s Accounts Receivable allowance for doubtful accounts for the six months ended June 30, 2023 and 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_zNQ123XCh256" style="display: none">SCHEDULE OF ACCOUNTS RECEIVABLE ALLOWANCE FOR DOUBTFUL ACCOUNTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td> <td style="text-align: center; font-weight: bold"> </td> <td colspan="2" id="xdx_490_20230101__20230630__us-gaap--FairValueByAssetClassAxis__us-gaap--AccountsReceivableMember_z3vp39dUQILk" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2023</td> <td style="text-align: center; font-weight: bold"> </td> <td style="text-align: center; font-weight: bold"> </td> <td colspan="2" id="xdx_49C_20220101__20220630__us-gaap--FairValueByAssetClassAxis__us-gaap--AccountsReceivableMember_z5p4Sai0Eu97" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td> <td style="text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="text-align: center; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">For the Six Months ended June 30,</td> <td style="text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2023</td> <td style="text-align: center; font-weight: bold"> </td> <td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td> <td style="text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr id="xdx_400_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_z8msDPzrt157" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Beginning balance</td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 16%; text-align: right">272,550</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 16%; text-align: right">213,787</td> <td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--ProvisionForDoubtfulAccounts_zepNruqi2NDk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">(Reversal of) provision for bad debts</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0714">-</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">47,857</td> <td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--AllowanceForDoubtfulAccountsReceivableRecoveries_iN_di_zcKPhbJSqXnd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Recoveries/Write offs</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">(51,853</td> <td style="text-align: left">)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0718">-</span></td> <td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_iN_di_z03weekfR3jc" style="vertical-align: bottom; background-color: White"> <td>Effect of translation</td> <td> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(20,653</td> <td style="text-align: left">)</td> <td> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(11,933</td> <td style="text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_ztPiXtsUhSu1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Ending balance</td> <td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right">200,044</td> <td style="text-align: left"> </td> <td> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right">249,711</td> <td style="text-align: left"> </td></tr> </table>
	AIXN	Provision For Inventory Reserve ProvisionForInventoryReserve	12026	usd
CY2023Q2	us-gaap	Property Plant And Equipment Salvage Value Percentage PropertyPlantAndEquipmentSalvageValuePercentage	0.05	pure
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	807529	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	3823770	usd
	us-gaap	Revenue Recognition Deferred Revenue RevenueRecognitionDeferredRevenue	<p id="xdx_849_eus-gaap--RevenueRecognitionDeferredRevenue_zdiRbpj7L8Ll" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white"><b><span id="xdx_866_zzdEAbj5hAd9">Unearned Revenue</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">The Company’s unearned revenue primarily consists of advances received from customers for the purchase of products prior to the delivery of goods, and for the rental of hotel rooms prior to the delivery of service. The delivery of products and room rental services is (normally within one year) based upon contract terms and customer demand.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2023Q2	us-gaap	Short Term Non Bank Loans And Notes Payable ShortTermNonBankLoansAndNotesPayable	82744	usd
CY2022Q4	us-gaap	Short Term Non Bank Loans And Notes Payable ShortTermNonBankLoansAndNotesPayable	86992	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1078308	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_846_eus-gaap--ConcentrationRiskCreditRisk_zjpdcDEtbgrh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white"><b><span id="xdx_863_z9LIlLM3PWE2">Concentration of Credit Risk</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">The operations of the Company are in the PRC. Accordingly, the Company’s business, financial condition, and results of operations may be influenced by the political, economic, and legal environments in the PRC, and by the general state of the PRC economy.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">The Company has cash on hand and demand deposits in accounts maintained with state-owned banks within the PRC. Cash in state-owned banks is covered by insurance up to RMB <span id="xdx_905_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_uRMB_c20230630_zO88Av717ASk">500,000</span> ($<span id="xdx_905_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_uUSD_c20230630_z6RQeF8SZPM6" title="Cash FDIC insured amount">72,500</span>) per bank. The Company has not experienced any losses in such accounts and believes they are not exposed to any risks on its cash in these bank accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">During the three and six months ended June 30, 2023 and 2022, the Company had no customer that accounted for over <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_zdopYihSDlDg"><span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_zgLkR2aZ4Zwl"><span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20230401__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_zC2n3iKga19b"><span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_zzdxF7fw8iY">10</span></span></span></span>% of its total revenue.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">During the three months ended June 30, 2023, the Company had one supplier that accounted for <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20230401__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfSalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierOneMember_zLOLTQz8KGof" title="Concentration risk, percentage">15</span>% of its total purchases.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">During the six months ended June 30, 2023, the Company had two suppliers that accounted for <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfSalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierOneMember_zZpodbsvviVi">15</span>% and <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfSalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierTwoMember_zU9Zi0ZI5VJi">13</span>%, respectively, of its total purchases.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">During the three months ended June 30, 2022, the Company had one supplier that accounted for <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfSalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierOneMember_zGOdCk3k77Nb" title="Concentration risk, percentage">23</span>% of its total purchases.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">During the six months ended June 30, 2022, the Company had one supplier that accounted for <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfSalesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierOneMember_z3CydNuadAEd" title="Concentration risk, percentage">12</span>% of its total purchases.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2023Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	500000
CY2023Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	72500	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1476057	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	420887	usd
CY2023Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1580825	usd
CY2022Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1160125	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-104768	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-739238	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2230770	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	839565	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	2887508	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	2350957	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-656738	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1511392	usd
CY2023Q2	us-gaap	Assets Assets	4227098	usd
CY2022Q4	us-gaap	Assets Assets	5050884	usd
CY2023Q2	us-gaap	Deposit Assets DepositAssets	12320	usd
CY2022Q4	us-gaap	Deposit Assets DepositAssets	15546	usd
CY2023Q2	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	19768	usd
CY2022Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	9490	usd
CY2023Q2	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	9904	usd
CY2022Q4	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	10124	usd
CY2023Q2	us-gaap	Other Assets OtherAssets	24339	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	7471	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	66331	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	42631	usd
CY2023Q2	us-gaap	Supplies Supplies	156745	usd
CY2022Q4	us-gaap	Supplies Supplies	168523	usd
CY2023Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	142571	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	62462	usd
CY2023Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	2742	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	15315	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	521	usd
CY2023Q2	AIXN	Inventory Drugs Pharmaceutical And Nutritional Products Gross InventoryDrugsPharmaceuticalAndNutritionalProductsGross	491936	usd
CY2022Q4	AIXN	Inventory Drugs Pharmaceutical And Nutritional Products Gross InventoryDrugsPharmaceuticalAndNutritionalProductsGross	412129	usd
CY2023Q2	AIXN	Inventory Food And Beverage Hotel Supplies And Consumables Gross InventoryFoodAndBeverageHotelSuppliesAndConsumablesGross	70211	usd
CY2022Q4	AIXN	Inventory Food And Beverage Hotel Supplies And Consumables Gross InventoryFoodAndBeverageHotelSuppliesAndConsumablesGross	82646	usd
CY2023Q2	us-gaap	Inventory Gross InventoryGross	707460	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	573073	usd
CY2023Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	81708	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	73821	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	625752	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	499252	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2795500	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2928342	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1094193	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	956549	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1701307	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1971793	usd
CY2023Q2	us-gaap	Depreciation Depreciation	88509	usd
CY2022Q2	us-gaap	Depreciation Depreciation	26947	usd
	us-gaap	Depreciation Depreciation	192909	usd
	us-gaap	Depreciation Depreciation	55925	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	10675	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	8564	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7434	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7295	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3241	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1269	usd
CY2023Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	357	usd
CY2022Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	633	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	518	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1294	usd
CY2023Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	103636	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	104100	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	682694	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	999285	usd
CY2023Q2	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	250302	usd
CY2022Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	270349	usd
CY2023Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	347562	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	307331	usd
CY2023Q2	us-gaap	Accrued Rent Current AccruedRentCurrent	49916	usd
CY2022Q4	us-gaap	Accrued Rent Current AccruedRentCurrent	32746	usd
CY2023Q2	us-gaap	Construction Payable Current ConstructionPayableCurrent	1217754	usd
CY2022Q4	us-gaap	Construction Payable Current ConstructionPayableCurrent	1384674	usd
CY2023Q2	AIXN	Payable For Equipment Purchase Current PayableForEquipmentPurchaseCurrent	23689	usd
CY2022Q4	AIXN	Payable For Equipment Purchase Current PayableForEquipmentPurchaseCurrent	32278	usd
CY2023Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	194393	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	233894	usd
CY2023Q2	us-gaap	Deposit Liability Current DepositLiabilityCurrent	11084	usd
CY2022Q4	us-gaap	Deposit Liability Current DepositLiabilityCurrent	11308	usd
CY2023Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	48731	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	83910	usd
CY2023Q2	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	2143431	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	2356490	usd
CY2023Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	207035	usd
CY2022Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	220203	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	417369	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	449445	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	405079	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	418711	usd
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y5M15D
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y10M28D
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0475	pure
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0475	pure
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	543223	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	150094	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	88611	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	37969	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	8274	usd
CY2023Q2	AIXN	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	3448	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	831619	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	24090	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	807529	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	601626	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	205903	usd
CY2023Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	134320	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	83102	usd
CY2023Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	134320	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	83102	usd
CY2023Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	204443	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	236882	usd
CY2023Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	204443	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	236882	usd
CY2014Q2	us-gaap	Payments For Rent PaymentsForRent	5000
CY2014Q2	us-gaap	Payments For Rent PaymentsForRent	690	usd
CY2014Q2	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2028-05-28
CY2023Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd
CY2022Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd
	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd
	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd
CY2020Q3	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	one (1)-for-four (4) reverse stock
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
	us-gaap	Stock Issued During Period Shares Reverse Stock Splits StockIssuedDuringPeriodSharesReverseStockSplits	24999842	shares
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	92885	usd
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation	92885	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	185770	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	185770	usd
CY2023Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	486897	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y3M25D
	AIXN	Net Income Transfer Percentage NetIncomeTransferPercentage	0.10	pure
	AIXN	Capital Reserve Percentage CapitalReservePercentage	0.50	pure
CY2023Q2	AIXN	Statutory Reserve Fund StatutoryReserveFund	0	usd
CY2022Q2	AIXN	Statutory Reserve Fund StatutoryReserveFund	0	usd
	AIXN	Statutory Reserve Fund StatutoryReserveFund	0	usd
	AIXN	Statutory Reserve Fund StatutoryReserveFund	0	usd
	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<p id="xdx_802_eus-gaap--LossContingencyDisclosures_zA7PkiJ7MCOc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white"><b>16. <span><span id="xdx_829_zV2VzTjkG63i">OPERATING CONTINGENCIES</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">The Company’s operations in the PRC are subject to specific considerations and significant risks not typically associated with companies in North America and Western Europe. These include risks associated with, among others, the political, economic and legal environments and foreign currency exchange. The Company’s results may be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, currency conversion and remittance abroad, and rates and methods of taxation, among other things.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">The Company’s sales, purchases and expenses are denominated in RMB and all of the Company’s assets and liabilities are also denominated in RMB. The RMB is not freely convertible into foreign currencies under the current law. In China, foreign exchange transactions are required by law to be transacted only by authorized financial institutions. Remittances in currencies other than RMB may require certain supporting documentation to affect the remittance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white"><b>Litigation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">The Company is, from time to time, involved in litigation incidental to the conduct of its business regarding merchandise sold, employment matters, and litigation regarding intellectual property rights.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">In December 2020, Jian Yiao (the “Plaintiff”) filed a complaint against Chengdu Aixintang Pharmacy Co., Ltd. (“Aixintang Pharmacy”, or the “Defendant”) in Zhangjiagang People’s Court in Jiangsu Province. The complaint alleges that Jian Yiao is entitled to $<span id="xdx_908_eus-gaap--LongTermPurchaseCommitmentAmount_uUSD_c20201201__20201231_zCCskdF7FTtj" title="Purchase commitment amount">392,305</span> (RMB <span id="xdx_90D_eus-gaap--LongTermPurchaseCommitmentAmount_uRMB_c20201201__20201231_zQiZKFLbS8Pj" title="Purchase commitment amount">2,500,000</span>) from Aixintang Pharmacy for not fulfilling the contractual obligation of a purchase agreement entered in March 2020 (the “Purchase Agreement”). Aixintang Pharmacy claimed that the Purchase Agreement was falsely entered by an employee through forged documents, and that Aixintang Pharmacy did not enter the Purchase Agreement. The Court determined that Aixintang Pharmacy breached the Purchase Agreement by not delivering the products ordered and ordered Aixintang Pharmacy to pay $<span id="xdx_905_eus-gaap--LitigationSettlementExpense_uUSD_c20201201__20201231_znUHWSbPwdVh" title="Litigation settlement expense">392,305</span> (RMB <span id="xdx_908_eus-gaap--LitigationSettlementExpense_uRMB_c20201201__20201231_z9MGHHfTbFtk" title="Litigation settlement expense">2,500,000</span>) to the Plaintiff. In December 2020, Aixintang Pharmacy filed a motion in the Jiangsu Suzhou Intermediate People’s Court against the determination reached from the first trial.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">In February 2021, the judge in the Jiangsu Suzhou Intermediate People’s Court denied the Defendant’s motion and upheld the judgment from the first trial. In March 2021, Aixintang Pharmacy filed another motion to the Jiangsu High People’s Court on the basis that the Purchase Agreement was forged. In February 2022, Aixintang Pharmacy filed an appeal in Jiangsu High People’s Court against the judgment reached by Jiangsu Suzhou Intermediate People’s Court in February 2021. To date, this legal proceeding remains pending.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">In November 2021, the Company and Mr. Quanzhong Lin agreed that Mr. Lin shall assume any losses arising from this legal proceeding. As such, the Company did not accrue contingent losses from this legal proceeding as of June 30, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">The Company believes that current pending litigation will not have a material adverse effect on its consolidated financial position, results of operations or cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2020Q4	us-gaap	Long Term Purchase Commitment Amount LongTermPurchaseCommitmentAmount	392305	usd
CY2020Q4	us-gaap	Long Term Purchase Commitment Amount LongTermPurchaseCommitmentAmount	2500000
CY2020Q4	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	392305	usd
CY2020Q4	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	2500000
CY2022Q2	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	548308	usd
CY2022Q2	AIXN	Business Acquisitions Pro Forma Cost Of Goods And Services Sold BusinessAcquisitionsProFormaCostOfGoodsAndServicesSold	1336027	usd
CY2022Q2	AIXN	Business Acquisitions Pro Forma Loss From Operations BusinessAcquisitionsProFormaLossFromOperations	-787719	usd
CY2022Q2	AIXN	Business Acquisitions Pro Forma Other Nonoperating Income Expense BusinessAcquisitionsProFormaOtherNonoperatingIncomeExpense	30167	usd
CY2022Q2	AIXN	Business Acquisitions Pro Forma Income Tax Expense Benefit BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit	473	usd
CY2022Q2	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-758025	usd
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	1050147	usd
	AIXN	Business Acquisitions Pro Forma Cost Of Goods And Services Sold BusinessAcquisitionsProFormaCostOfGoodsAndServicesSold	2620971	usd
	AIXN	Business Acquisitions Pro Forma Loss From Operations BusinessAcquisitionsProFormaLossFromOperations	-1570824	usd
	AIXN	Business Acquisitions Pro Forma Other Nonoperating Income Expense BusinessAcquisitionsProFormaOtherNonoperatingIncomeExpense	50768	usd
	AIXN	Business Acquisitions Pro Forma Income Tax Expense Benefit BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit	965	usd
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-1521021	usd

Files In Submission

Name	View Source	Status
0001493152-23-029386-index-headers.html	Edgar Link	pending
0001493152-23-029386-index.html	Edgar Link	pending
0001493152-23-029386.txt	Edgar Link	pending
0001493152-23-029386-xbrl.zip	Edgar Link	pending
aixn-20230630.xsd	Edgar Link	pending
aixn-20230630_def.xml	Edgar Link	unprocessable
aixn-20230630_cal.xml	Edgar Link	unprocessable
aixn-20230630_lab.xml	Edgar Link	unprocessable
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
aixn-20230630_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AIXN
AiXin Life International, Inc. Stock $aixn

2023 Q3 Form 10-Q Financial Statement

#000149315223029386 Filed on August 18, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AIXN AiXin Life International, Inc. Stock $aixn

2023 Q3 Form 10-Q Financial Statement

#000149315223029386 Filed on August 18, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AIXN
AiXin Life International, Inc. Stock $aixn